Anna Russo
Vice President, Machine Learning and Artificial Intelligence
8 May, 2025
As safety data volumes grow across clinical development and post-marketing stages, organizations must balance innovation with regulatory compliance, data integrity, and patient safety. The focus is shifting from manual, reactive PV processes to a structured, technology-enabled approach that strengthens signal detection, operational efficiency, and regulatory readiness.
Apply AI in PV with confidence. Speak to our team.
– How AI can be applied to optimize pharmacovigilance activities across the lifecycle
– How to improve signal detection and risk management using AI-driven tools
– How to address key challenges in AI implementation and system integration
– How real-world AI use cases are transforming PV operations today
– How AI may shape the future of drug safety and compliance
Vice President, Machine Learning and Artificial Intelligence
This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.